1 / 21

What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer

What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer. Program Goals. Ovarian Cancer Overview. PARP Inhibition in Ovarian Cancer. Testing for BRCA1/2 Mutations. PARP Inhibitors Under Development. Olaparib in Patients With BRCA1 / BRCA2 Ovarian Cancer.

thane
Télécharger la présentation

What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer

  2. Program Goals

  3. Ovarian Cancer Overview

  4. PARP Inhibition in Ovarian Cancer

  5. Testing for BRCA1/2 Mutations

  6. PARP Inhibitors Under Development

  7. Olaparib in Patients With BRCA1/BRCA2 Ovarian Cancer

  8. PARP Inhibitors in Patients With BRCA1/BRCA2 Ovarian Cancer

  9. PARP Inhibitors as Maintenance Therapy

  10. Biomarkers to Measure PARP Inhibitor Response

  11. PARP Inhibitors and Chemotherapy

  12. Olaparib Maintenance Therapy

  13. Velaparib in Patients With Recurrent Disease

  14. Major Toxicities of PARP Inhibitors

  15. Outstanding Questions

  16. Abbreviations

  17. References

  18. References (cont)

  19. References (cont)

  20. References (cont)

More Related